Osteochondral Regeneration in the Knee Joint with Autologous Peripheral Blood Stem Cells plus Hyaluronic Acid after Arthroscopic Subchondral Drilling: Report of Five Cases

Abstract

Background:: Treatment of osteochondral defects (OCDs) of the knee joint remains challenging. The purpose of this study was to evaluate the clinical and radiological results of osteochondral regeneration following intra-articular injections of autologous peripheral blood stem cells (PBSC) plus hyaluronic acid (HA) after arthroscopic subchondral drilling into OCDs of the knee joint.

Case Presentation:: Five patients with OCDs of the knee joint are presented. The etiology includes osteochondritis dissecans, traumatic knee injuries, previously failed cartilage repair procedures involving microfractures and OATS (osteochondral allograft transfer systems). PBSC were harvested 1 week after surgery. Patients received intra-articular injections at week 1, 2, 3, 4, and 5 after surgery. Then at 6 months after surgery, intra-articular injections were administered at a weekly interval for 3 consecutive weeks. These 3 weekly injections were repeated at 12, 18 and 24 months after surgery. Each patient received a total of 17 injections. Subjective International Knee Documentation Committee (IKDC) scores and MRI scans were obtained preoperatively and postoperatively at serial visits. At follow-ups of >5 years, the mean preoperative and postoperative IKDC scores were 47.2 and 80.7 respectively (p = 0.005). IKDC scores for all patients exceeded the minimal clinically important difference values of 8.3, indicating clinical significance. Serial MRI scans charted the repair and regeneration of the OCDs with evidence of bone growth filling-in the base of the defects, followed by reformation of the subchondral bone plate and regeneration of the overlying articular cartilage.

Conclusion:: These case studies showed that this treatment is able to repair and regenerate both the osseous and articular cartilage components of knee OCDs.

Keywords

Arthroscopic Subchondral Drilling / Bone and Articular Cartilage Regeneration / Bone Marrow Stimulation / Osteochondral Defects / Peripheral Blood Stem Cells

References

[1] Krych AJ, Saris DBF, Stuart MJ, Hacken B. Cartilage injury in the knee: assessment and treatment options. J Am Acad Orthop Surg. 2020;28(22):914–922.

[2] Takeda M, Higuchi H, Kimura M, Kobayashi Y, Terauchi M, Takagishi K. Spontaneous osteonecrosis of the knee: histopathological differences between early and progressive cases. J Bone Jt Surg Br. 2008;90(3):324–329.

[3] Jose J, Pasquotti G, Smith MK, Gupta A, Lesniak BP, Kaplan LD. Subchondral insufficiency fractures of the knee: review of imaging findings. Acta Radiol. 2015;56(6):714–719.

[4] Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009;37(1):2053–2063.

[5] Mithoefer K, Gill TJ, Cole BJ, Williams RJ, Mandelbaum BR. Clinical outcome and return to competition after microfracture in the athlete's knee: an evidence-based systematic review. Cartilage. 2010;1(2):113–120.

[6] Bert JM. Abandoning microfracture of the knee: has the time come. Arthroscopy. 2015;31(3):501–505.

[7] Anderson DE, Rose MB, Wille AJ, Wiedrick J, Crawford DC. Arthroscopic mechanical chondroplasty of the knee is beneficial for treatment of focal cartilage lesions in the absence of concurrent pathology. Orthop J Sports Med. 2017;5(5):232596711770721.

[8] Bisson LJ, Kluczynski MA, Wind WM, Fineberg MS, Bernas GA, Rauh MA, et al. Patient outcomes after observation versus debridement of unstable chondral lesions during partial meniscectomy: the chondral lesions and meniscus procedures (ChAMP) randomized controlled trial. J Bone Jt Surg Am. 2017;99(13):1078–1085.

[9] Snow M, Middleton L, Mehta S, Roberts A, Gray R, Richardson J, et al. A randomized trial of autologous chondrocyte implantation versus alternative forms of surgical cartilage management in patients with a failed primary treatment for chondral or osteochondral defects in the knee. Am J Sports Med. 2023;51(2):367–378.

[10] Kunze KN, Ramkumar PN, Manzi JE, Wright-Chisem J, Nwachukwu BU, Williams RJ. Risk factors for failure after osteochondral allograft transplantation of the knee: a systematic review and exploratory meta-analysis. Am J Sports Med. 2023;51(5):1356–1367.

[11] Cavendish PA, Everhart JS, Peters NJ, Sommerfeldt MF, Flanigan DC. Osteochondral allograft transplantation for knee cartilage and osteochondral defects: a review of indications, technique, rehabilitation, and outcomes. JBJS Rev. 2019;7(6):1–12.

[12] Levy TD, Görtz S, Pulido PA, McCauley JC, Bugbee WD. Do fresh osteochondral allografts successfully treat femoral condyle lesions. Clin Orthop Relat Res. 2013;471(1):231–237.

[13] Bartlett W, Skinner JA, Gooding CR, Carrington RW, Flanagan AM, Briggs TW, et al. Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective randomized study. J Bone Jt Surg Br. 2005;87(5):640–645.

[14] Brittberg M, Recker D, Ilgenfritz J, Saris DBF. Matrix-applied characterized autologous cultured chondrocytes versus microfracture: five-year follow-up of a prospective randomized trial. Am J Sports Med. 2018;46(6):1343–1351.

[15] Saw KY, Anz A, Merican S, Tay YG, Ragavanaidu K, Jee CSY, et al. Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic acid after arthroscopic subchondral drilling: a report of 5 cases with histology. Arthroscopy. 2011;27(4):493–506.

[16] Saw KY, Anz A, Jee CSY, Merican S, Ng RCS, Roohi SA, et al. Articular cartilage regeneration with autologous peripheral blood stem cells versus hyaluronic acid: a randomized controlled trial. Arthroscopy. 2013;29(4):684–694.

[17] Saw KY, Anz A, Ng RCS, Jee CSY, Low SF, Dorvault C, et al. Arthroscopic subchondral drilling with peripheral blood stem cells plus hyaluronic acid versus hyaluronic acid plus physiotherapy in massive knee chondral defects: a randomized controlled trial. Arthroscopy. 2021;37(8):2502–2517.

[18] Saw KY, Gill R, Low TC. Massive tibial bone regeneration with autologous peripheral blood stem cells using Ilizarov bone transport: a case report. Malays Orthop J. 2020;14(3):166–169.

[19] Anz AW, Torres J, Plummer HA, Jee CSY, Dekker TJ, Saw KY. Mobilized peripheral blood stem cells are pluripotent and can be safely harvested and stored for cartilage repair. Arthroscopy. 2021;37:3347–3356.

[20] Saw KY, Anz A, Jee CSY, Ng RCS, Mohtarrudin N, Ragavanaidu K. High tibial osteotomy in combination with chondrogenesis after stem cell therapy: a histologic report of 8 cases. Arthroscopy. 2015;31(10):1909–1920.

[21] Gorbachova T, Melenevsky Y, Cohen M, Cerniglia BW. Osteochondral lesions of the knee: differentiating the most common entities at MRI. Radiographics. 2018;38(5):1478–1495.

[22] Saw KY, Jee CSY. From blade runner to stem cell player and beyond. Bone Joint. 2013;2(1):6–11.

[23] Saw KY, Jee CSY, Ramlan A, Dawam A, Saw YC, Low SF. Osteochondrogenesis with autologous peripheral blood stem cells for osteochondral lesions of the talus: report of five cases. Malays Orthop J. 2022;16(3):128–131.

[24] Saw KY, Anz AW, Jee CSY, Ramlan A, Dawam A, Low SF. Chondrogenesis with autologous peripheral blood stem cells for end-stage ankle arthritis: report of three cases. Malays Orthop J. 2022;16(1):134–137.

[25] Saw KY, Low SF, Ramlan A, Dawam A, Saw YC, Jee CSY. Autologous peripheral blood stem cell therapy for chronic Achilles tendinopathy: report of three cases. Malays Orthop J. 2022;16(2):150–154.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.